Argon laser peripheral iridoplasty in the management of phacomorphic glaucoma.

Background And Objective: To document the efficacy and safety of argon laser peripheral iridoplasty (ALPI) as a temporizing measure in the treatment of phacomorphic glaucoma and to evaluate the mid-term visual outcomes.

Patients And Methods: The clinical records of all patients with phacomorphic glaucoma treated with ALPI from December 1999 to December 2002 were retrospectively reviewed. The primary outcome measure was the rate of successful control of intraocular pressure.